Banner%202_edited.jpg

EVENTS

  • Clinical Evidence Webinar
    RSVP Closed
    Clinical Evidence Webinar
    Thu, 25 Feb
    Webex
    25 Feb, 14:00 – 16:00
    Webex
    SEHTA and Psephos are hosting a webinar on Clinical Evidence on Thursday 25th February 2021. We have developed this 2 hour webinar in light of the new UK product marking that will be used for goods being placed on the market in Great Britain (England, Wales & Scotland).
    Share
    Details
  • Software UKCA Marking Webinar
    RSVP Closed
    Software UKCA Marking Webinar
    Thu, 04 Feb
    Webex
    04 Feb, 14:00 – 16:00 GMT
    Webex
    SEHTA and Psephos Software UKCA Marking Webinar takes places on Thursday 4th February 2021. This 2 hour webinar will help guide you through the changes taking place from 1st January 2021.
    Share
    Details
  • CE & UKCA Marking Webinar
    RSVP Closed
    CE & UKCA Marking Webinar
    Thu, 14 Jan
    Webex
    14 Jan, 14:00 – 16:00 GMT
    Webex
    SEHTA and Psephos latest MDR webinar is on CE & UKCA Marking. We have developed this 2 hour webinar in light of the new UK product marking that will be used for goods being placed on the market in Great Britain (England, Wales & Scotland).
    Share
    Details
  • Brexit/UKCA Marking Webinar
    RSVP Closed
    Brexit/UKCA Marking Webinar
    Thu, 10 Dec
    Webex
    10 Dec 2020, 14:00 – 14:30 GMT
    Webex
    SEHTA and Psephos Biomedica are running a series of FREE TO ATTEND webinars on Brexit/UKCA Marking.
    Share
    Details
  • Brexit/UKCA Marking Webinar
    RSVP Closed
    Brexit/UKCA Marking Webinar
    Thu, 03 Dec
    Webex
    03 Dec 2020, 14:00 – 14:30
    Webex
    SEHTA and Psephos Biomedica are running a series of FREE TO ATTEND webinars on Brexit/UKCA Marking.
    Share
    Details
  • Brexit/UKCA Marking Webinar
    RSVP Closed
    Brexit/UKCA Marking Webinar
    Thu, 05 Nov
    Webex
    05 Nov 2020, 14:00 – 14:30 GMT
    Webex
    Share
    Details
  • Brexit/UKCA Marking Webinar
    RSVP Closed
    Brexit/UKCA Marking Webinar
    Thu, 15 Oct
    Webex
    15 Oct 2020, 14:00 – 14:30 BST
    Webex
    SEHTA and Psephos are are running this FREE TO ATTEND webinar on Brexit/UKCA Marking.
    Share
    Details
  • SEHTA’s 2020 International MedTech Expo & Conference
    RSVP Closed
    SEHTA’s 2020 International MedTech Expo & Conference
    Mon, 28 Sep
    Webex
    28 Sep 2020, 12:00 – 13:00 BST
    Webex
    Psephos are pleased to announce that we’ve signed up as an exhibitor at SEHTA’s 2020 International MedTech Expo & Conference. Join us!
    Share
    Details
  • MDR/IVDR Technical File, Risk Management, QMS Workshop
    RSVP Closed
    MDR/IVDR Technical File, Risk Management, QMS Workshop
    Thu, 21 May
    Webex
    21 May 2020, 14:00 BST
    Webex
    SEHTA and Psephos Biomedica are running their next workshop on MDR/IVDR Technical File/Risk Management/QMS.
    Share
    Details
  • EU Medical Device & InVitro Diagnostic CE Marking Workshop
    RSVP Closed
    EU Medical Device & InVitro Diagnostic CE Marking Workshop
    Tue, 28 Apr
    Webex
    28 Apr 2020, 14:00 BST
    Webex
    SEHTA and Psephos Biomedica are pleased to run their first workshop in the Cambridge area on EU Medical Device & InVitro Diagnostic CE Marking.
    Share
    Details
  • RSVP Closed
    Software/AI Medical Device EU MDR CE Marking Workshop
    Tue, 31 Mar
    Webex
    31 Mar 2020, 14:00 BST
    Webex
    SEHTA and Psephos Biomedica next workshop is on Software / AI Medical Device EU MDR CE Marking.
    Share
    Details
  • CE Marking & FDA Regulations Workshop
    RSVP Closed
    CE Marking & FDA Regulations Workshop
    Thu, 13 Feb
    Webex
    13 Feb 2020, 14:00 GMT
    Webex
    SEHTA and Psephos Biomedica are running their next workshop on CE Marking & FDA Regulations requirements.
    Share
    Details
  • In Vitro Diagnostic (IVD) New IVDR CE Marking Workshop
    RSVP Closed
    In Vitro Diagnostic (IVD) New IVDR CE Marking Workshop
    Thu, 16 Jan
    Webex
    16 Jan 2020, 14:00 GMT
    Webex
    The Invitro Diagnostic Regulations are in transition and companies need to understand and prepare for these significant changes.
    Share
    Details